MGX News

In February, 10 IPOs raised a combined $2.0 billion, led by early debuts from a handful of $100+ million offerings. Deal flow was led by healthcare and senior facilities provider American Healthcare REIT (AHR) and Mexican discount grocer BBB Foods (TBBB), which together accounted for nearly two-thirds of the month's proceeds raised. Activity...read more

Six IPOs priced this past week, joined by two blank check companies. One larger deal did not get done: Fortegra (TFG) pulled its $297 million offering ahead of its expected pricing. The specialty insurer had previously attempted to go...read more

Metagenomi, a preclinical biotech using metagenomics-derived genome editing, raised $94 million by offering 6.3 million shares at $15, the low end of the range of $15 to $17. Metagenomi is a precision genetic medicines company developing curative therapeutics using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Its toolbox includes programmable...read more

Metagenomi, a preclinical biotech developing therapies using metagenomics-derived genome editing, announced terms for its IPO on Monday. The Emeryville, CA-based company plans to raise $100 million by offering 6.3 million shares at a price range of $15 to $17. At the midpoint of the proposed range, Metagenomi would command a market value of $600 million. Metagenomi is a precision...read more